CoChat

Antiglutamatergic Strategies for Ethanol Detoxification: Comparison With Placebo and Diazepam

Krupitsky, Evgeny M., Rudenko, Anatoly A., Burakov, Andrey M., Slavina, Tatyana Y., Grinenko, Alexander A., Pittman, Brian, Gueorguieva, Ralitza, Petrakis, Ismene L., Zvartau, Edwin E., Krystal, John H. · 2007 · Alcoholism: Clinical and Experimental Research
Cited by 130

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: Benzodiazepines are the standard pharmacotherapies for ethanol detoxification, but concerns about their abuse potential and negative effects upon the transition to alcohol abstinence drive the search for new treatments. Glutamatergic activation and glutamate receptor up‐regulation contribute to ethanol dependence and withdrawal. This study compared 3 antiglutamatergic strategies for ethanol detoxification with placebo and to the benzodiazepine, diazepam: the glutamate release inhibitor, lamotrigine; the N ‐methyl‐ d ‐aspartate glutamate receptor antagonist, memantine; and the AMPA/kainite receptor inhibitor, topiramate. Methods: This placebo‐controlled randomized single‐blinded psychopharmacology trial studied male alcohol‐dependent inpatients ( n =127) with clinically significant alcohol withdrawal symptoms. Subjects were assigned to 1 of 5 treatments for 7 days: placebo, diazepam 10 mg TID, lamotrigine 25 mg QID, memantine 10 mg TID, or topiramate 25 mg QID. Additional diazepam was administered when the assigned medication failed to suppress withdrawal symptoms adequately. Results: All active medications significantly reduced observer‐rated and self‐rated withdrawal severity, dysphoric mood, and supplementary diazepam administration compared with placebo. The active medications did not differ from diazepam. Conclusions: This study provides the first systematic clinical evidence supporting the efficacy of a number of antiglutamatergic approaches for treating alcohol withdrawal symptoms. These data support the hypothesis that glutamatergic activation contributes to human alcohol withdrawal. Definitive studies of each of these medications are now needed to further evaluate their effectiveness in treating alcohol withdrawal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1530-0277.2007.00344.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 130

Metadata

Authors
Krupitsky, E. M., Rudenko, A. A., Burakov, A. M., Slavina, T. Y., Grinenko, A. A., Pittman, B., Gueorguieva, R., Petrakis, I. L., Zvartau, E. E., & Krystal, J. H.
Venue
Alcoholism: Clinical and Experimental Research
Publisher
Wiley
Published
2007-02-12
Volume
31
Issue
4
Pages
604-611
ISSN
  • 0145-6008 (ISSN-L)
  • 1530-0277
OpenAlex
W2031898755
Cited by
130
References
3
FWCI
8.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiglutamatergic Strategies for Ethanol Detoxification: Comparison With Placebo and Diazepam. https://app.cochat.ai/papers/10.1111/j.1530-0277.2007.00344.x
The paper
Krupitsky, E. M., Rudenko, A. A., Burakov, A. M., Slavina, T. Y., Grinenko, A. A., Pittman, B., Gueorguieva, R., Petrakis, I. L., Zvartau, E. E., & Krystal, J. H. (2007). Antiglutamatergic Strategies for Ethanol Detoxification: Comparison With Placebo and Diazepam. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.2007.00344.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.